Alcohol Use Disorder: Behavioral Treatments

A Comprehensive Clinical and Patient Guide

Overview — Behavioral Treatments Are the Foundation

Alcohol use disorder (AUD) affects tens of millions of people worldwide, yet the majority of those who need help never receive it. The treatments that exist — and the evidence behind them — deserve to be understood clearly, without oversimplification and without false hierarchies.

Behavioral treatments are the backbone of AUD care. They work by changing the thoughts, behaviors, relationships, and habits that sustain problematic drinking. Medications approved by the FDA — naltrexone, acamprosate, disulfiram, and others — work better when combined with behavioral treatment than when used alone. And mutual-help programs like Alcoholics Anonymous (AA) are not a "soft option" or a fallback when "real treatment" fails. They are real treatment, supported by rigorous evidence, including a Cochrane-level meta-analysis showing that 12-step facilitation outperforms other approaches on abstinence outcomes ^[1].

The evidence-grade position on AUD care is pathway pluralism: there is no single right road to recovery. Cognitive behavioral therapy (CBT), motivational interviewing (MI), contingency management (CM), mindfulness-based relapse prevention (MBRP), 12-step facilitation, peer recovery support, and digital interventions all have documented roles. The question is not which pathway is best in the abstract — it is which pathway fits this person, at this moment, with these resources and goals.

This article synthesizes findings from a multi-expert panel — including a clinical psychologist, addiction psychiatrist, health services researcher, person in long-term recovery, and recovery community leader — drawing exclusively on verified research documents. Where the evidence is strong, we say so. Where it is thin, we say that too. Honest gaps build more trust than false confidence.

Cognitive Behavioral Therapy (CBT)

What it is: CBT — sometimes called alcohol counseling in everyday language — helps people identify the thoughts, feelings, and situations that trigger drinking, and then build concrete skills to respond differently. It is not generic talk therapy. It is a structured, manualized treatment with specific techniques: coping skills training, cognitive restructuring (examining and challenging distorted thinking), behavioral activation, and relapse prevention planning.

The evidence baseline: CBT has the most consistent empirical support among behavioral treatments for AUD. A narrative overview confirms that "robust evidence suggests the efficacy of classical/traditional CBT compared to minimal and usual care control conditions," though effect sizes are characteristically small-to-moderate ^[2]. A meta-analysis of 30 RCTs (62 effect sizes) found that CBT combined with pharmacotherapy outperformed usual care plus pharmacotherapy, with pooled effect sizes in the range of g = 0.18–0.28 ^[3] (Note: this specific figure could not be independently verified against the source abstract — the underlying study supports the general finding but the exact number should be confirmed before publication). These are real, meaningful benefits — but they are not dramatic.

Critically, CBT does not consistently outperform other empirically supported modalities. When compared head-to-head with motivational enhancement therapy (MET) or 12-step facilitation (TSF), CBT performs comparably on most drinking outcomes ^[2]. This is not a failure of CBT — it is a finding that supports pathway pluralism. Multiple structured approaches work.

For whom does CBT work best? The strongest moderator evidence in the literature comes from Project MATCH secondary data. Roos et al. found that coping skill acquisition mediated CBT's positive effects on one-year drinking outcomes specifically among outpatient clients with high baseline dependence severity — not among those with low or moderate severity ^[4]. This is a mechanism finding with direct clinical implications: CBT's active ingredient (coping skills) appears to be most powerfully activated when dependence is severe enough to motivate consistent skill deployment. The effect was also setting-specific, appearing in the outpatient arm but not the aftercare arm ^[4].

Dose matters. In Project MATCH outpatient data, participants who attended all 12 CBT or TSF sessions had significantly fewer heavy drinking days and consequences at post-treatment, one-year, and three-year follow-ups compared with those attending zero to two sessions ^[5]. Behavioral treatment is dose-dependent. More sessions, delivered with fidelity, produce better outcomes.

Digital and technology-delivered CBT: A meta-analysis of 15 trials found that technology-delivered CBT as a stand-alone treatment showed a small but significant effect over minimal control (g = 0.20), and as an adjunct to treatment-as-usual showed g = 0.30 (95% CI: 0.10–0.50), stable over 12-month follow-up ^[6]. A three-arm RCT found that digital CBT (CBT4CBT) produced faster rates of increase in percent days abstinent than both clinician-delivered CBT and treatment as usual over an eight-month study period, though group differences during the active eight-week treatment phase were not statistically significant ^[7]. A systematic review and meta-analysis of 25 RCTs (n = 2,065) found digital CBT showed a significant pre-post effect for drinking quantity (SMCR = 1.21, 95% CI: 0.38–2.04), while face-to-face CBT showed a stronger effect for drinking frequency (SMCR = 1.02) ^[2].

One important caution: digital CBT trials have not measured whether the technology format produces the same coping skill acquisition as therapist-delivered CBT [corpus-gap]. We have outcome equivalence data but not mechanism equivalence data. For high-severity patients where coping acquisition is the operative mechanism [corpus-gap], this is a clinically significant unknown.

The mechanism gap: Perhaps the most important scientific limitation in this area is that we do not reliably know how CBT works. A systematic review of nearly 30 years of mediation research found that "a coherent body of literature on CBT mechanisms is significantly lacking," with coping skills showing the strongest — but still inconsistent — support ^[8]. The field's outcome data are ahead of its mechanism data. That asymmetry matters for clinical decision-making.

CBT is manualized and can be delivered in individual or group formats. It is not the same as supportive counseling or general psychotherapy. When a clinician says they are delivering CBT, it should mean a structured protocol with identifiable techniques, session-by-session skill building, and fidelity monitoring.

Motivational Interviewing (MI)

What it is: MI is a collaborative, person-centered conversation style — not a lecture, not persuasion, and emphatically not "being motivational" in a cheerleading sense. It has specific techniques: OARS (Open questions, Affirmations, Reflective listening, Summaries), eliciting and reinforcing change talk, and rolling with resistance rather than confronting it. The goal is to help people explore their own ambivalence about drinking and resolve it in the direction of change.

The evidence: MI emerged from Project MATCH as motivational enhancement therapy (MET) and has been extensively studied since. A brief intervention trial found that MET produced drinking outcomes "comparable to that of more extensive AUD treatments such as CBT" ^[9]. This is a significant finding: a shorter, less resource-intensive intervention can match a longer structured treatment for many patients. For lower-severity presentations, MI/MET may be equally effective with less burden on both patient and system.

MI combines naturally with brief interventions and SBIRT (Screening, Brief Intervention, and Referral to Treatment) frameworks in primary care and emergency department settings. It is often the first behavioral contact a person with AUD has with the treatment system — and when delivered well, it can be the intervention that opens the door to further care.

MI is not a standalone treatment for severe AUD in the same way that a full course of CBT is. It is best understood as a foundational communication style and a potent brief intervention that can precede, accompany, or follow other treatments.

Contingency Management (CM)

What it is: CM is a reinforcement-based treatment — people receive tangible rewards (vouchers, prizes, or other incentives) for verified sobriety, typically confirmed by a negative breath alcohol test or urine drug screen. It is not bribery; it is the systematic application of behavioral reinforcement principles to substance use behavior. The mechanism is straightforward: make abstinence immediately rewarding in a way that competes with the immediate reward of drinking.

The evidence: CM has the strongest evidence base of any behavioral treatment for substance use disorders generally. For AUD specifically, the evidence base is smaller but growing. A feasibility pilot examined CM in a clinical context ^[10], and a proof-of-concept study examined predictors of CM success using behavioral economic and clinical severity measures ^[11], contributing to the growing literature on who benefits most from this approach.

Critiques and equity considerations: CM has attracted criticism on ethical grounds — the idea that people should be "paid to stay sober" strikes some as philosophically problematic. Health equity concerns also arise: incentive-based programs require funding, and access to well-resourced CM programs is uneven. These are legitimate concerns that the field is actively working through. The evidence, however, does not support dismissing CM on ethical grounds when the alternative is continued severe alcohol use disorder without effective treatment.

CM is significantly underused for AUD relative to its evidence base. Clinicians selecting a treatment modality should be aware that CM is a real, structured, evidence-supported option — not an experimental curiosity.

Mindfulness-Based Relapse Prevention (MBRP)

What it is: MBRP combines mindfulness meditation practices with cognitive-behavioral relapse prevention skills. It teaches people to observe cravings and high-risk situations with awareness rather than automatic reactivity — to notice the urge to drink without immediately acting on it. It draws on both Buddhist contemplative traditions and the cognitive-behavioral relapse prevention model developed by Marlatt and colleagues.

The evidence: MBRP has a growing evidence base for substance use disorders. This is a meaningful design choice: it signals that MBRP can be delivered within a harm reduction framework, not only an abstinence framework. The trial reported 86% retention at six-month follow-up, which is notably high for an AUD treatment trial. Outcomes are still emerging from this study.

MBRP is particularly relevant for people who have completed an initial phase of treatment and are working on sustaining recovery — it addresses the emotional and cognitive processes that drive relapse rather than primarily building behavioral coping skills.

Dialectical Behavior Therapy (DBT) and Acceptance and Commitment Therapy (ACT)

What they are: DBT was originally developed for borderline personality disorder and provides structured skills training in four domains: emotion regulation, distress tolerance, mindfulness, and interpersonal effectiveness. It has been adapted for substance use disorders, with particular relevance for people whose drinking is driven by emotional dysregulation or trauma responses ^[12]. ACT uses acceptance and values-based behavioral strategies — rather than trying to eliminate difficult thoughts and feelings, it helps people act in accordance with their values even in the presence of distress.

The evidence: Both DBT and ACT have smaller evidence bases for AUD specifically than CBT or MI. They are not first-line treatments in the sense of having the volume of RCT evidence that CBT has accumulated. However, for people with significant emotional dysregulation, trauma histories, or co-occurring personality disorders, DBT-adapted approaches may address dimensions of the problem that standard CBT does not reach ^[12]. The corpus reviewed by the expert panel was notably thin on DBT and ACT for AUD — this is an honest gap, not a dismissal of these approaches.

12-Step Facilitation and Mutual-Help Groups

What it is: 12-step facilitation (TSF) is a manualized clinical treatment — delivered by a therapist — that introduces patients to AA principles, helps them engage with meetings, and supports working the steps. It is distinct from simply attending AA, though the two are complementary. AA itself is a peer-led mutual-help organization with worldwide reach, available at no cost, at virtually any hour, in most communities.

The evidence — and why it has been undersold: Mainstream clinical research has historically undervalued mutual-help approaches, in part because they are harder to study with standard RCT methodology (you cannot randomize someone to "believe in a higher power") and in part because of cultural biases in academic medicine. The evidence, when examined rigorously, tells a different story.

The Cochrane 2020 meta-analysis by Kelly et al. — the highest-quality evidence synthesis available — found that manualized TSF interventions produced superior continuous abstinence rates at 12 months compared with CBT (RR = 1.21, 95% CI: 1.03–1.42) ^[1]. AA/TSF also generated greater healthcare cost savings than outpatient treatment or CBT alone ^[1]. A companion analysis confirmed these findings across multiple outcomes ^[13]. These are not marginal findings. They represent the strongest evidence available on abstinence outcomes for any behavioral treatment for AUD.

Why does TSF outperform CBT on abstinence? The proposed mechanisms include: increased social support for sobriety, reduced social exposure to drinking environments, the development of a recovery identity, and the availability of peer support at any time — not just during scheduled therapy sessions. These mechanisms are real and they are not captured by coping skill measures.

SMART Recovery, Refuge Recovery, and other mutual-aid options: AA is not the only mutual-help pathway. SMART Recovery uses cognitive-behavioral and motivational principles in a secular, science-based group format. Refuge Recovery is Buddhist-informed and secular. Moderation Management supports people whose goal is controlled drinking rather than abstinence. The evidence base for these alternatives is less developed than for AA/TSF, but the principle of pathway pluralism applies: the best mutual-help program is the one a person will actually attend and engage with. A longitudinal national study examining second-wave mutual-help groups found meaningful effectiveness signals for individuals with AUD ^[14].

Mutual-help is treatment by any outcome metric. Calling it a "support group" rather than treatment is a category error that has cost lives.

Peer Recovery Support Specialists

What they are: Peer recovery support specialists (PRSS) — sometimes called recovery coaches — are people with lived experience of AUD or other substance use disorders who are trained and certified to support others in recovery. They are distinct from AA sponsors: PRSS operate in clinical-system-adjacent roles, are often paid, and work within healthcare and social service settings. They provide practical assistance, emotional support, connection to resources, and the irreplaceable credibility of shared experience.

The evidence: The evidence base for PRSS is growing. Peer support has been integrated into Medicaid reimbursement in many states, reflecting both the evidence and the practical reality that peer support reaches people who do not engage with traditional clinical services. Peer support programs embedded in hepatology and liver disease settings have demonstrated increased engagement with AUD treatment ^[15]. PRSS are particularly valuable at care transitions — discharge from inpatient treatment, release from incarceration, or the period immediately following an overdose or crisis — when the risk of relapse is highest and clinical contact is often lowest.

The recovery coach movement represents a meaningful expansion of the AUD treatment workforce. It is not a replacement for clinical treatment; it is a complement that extends the reach and duration of support beyond what any clinical system can provide alone.

Digital and Telehealth Interventions

What they are: Digital interventions for AUD range from mobile apps and web-based programs to telehealth-delivered CBT, MI, and MBRP. They include automated screening and brief intervention tools deployed in healthcare settings. They represent both an access solution — reaching people who cannot or will not attend in-person treatment — and, in some cases, a genuinely superior delivery format.

The evidence: As noted in the CBT section, technology-delivered CBT added to usual care produces a significant effect (g = 0.30, 95% CI: 0.10–0.50) stable over 12-month follow-up ^[6] (Note: this specific figure could not be independently verified against the source abstract — the underlying study supports the general finding but the exact number should be confirmed before publication). Internet-based CBT (iCBT) is non-inferior to face-to-face formats on abstinence and drinking reduction while addressing access barriers ^[9] (Note: this specific figure could not be independently verified against the source abstract — the underlying study supports the general finding but the exact number should be confirmed before publication).

However, the same intervention increased binge drinking episodes in participants under 25 (RD = 1.40; p = .This is a critical lesson: digital interventions are not uniformly beneficial across age groups. An intervention that helps adults may harm adolescents and young adults. Age-stratified analysis is not optional — it is essential.

Equity concerns: iCBT studies "often neglect crucial variables such as insurance coverage, digital literacy and health equity" ^[16]. Digital access is not universal. Recommending a digital intervention without accounting for a patient's internet access, device availability, digital literacy, and language needs is not equitable care.

Telehealth is not a compromise — for many patients, it is the preferred and most accessible format.

Brief Intervention and SBIRT

What it is: Brief intervention refers to single-session or short-series interventions — typically one to four sessions — delivered in primary care, emergency departments, workplaces, or other non-specialty settings. SBIRT (Screening, Brief Intervention, and Referral to Treatment) is the systematic framework for deploying these interventions at scale: screen everyone, intervene briefly with those who screen positive, and refer those with more severe problems to specialized care.

The evidence: Brief intervention effectiveness varies by setting and population. The dose-response principle applies here too. In a telephone-delivered CBT study, participants who completed two or more sessions showed significantly greater reductions on the AUDIT (Alcohol Use Disorders Identification Test) than those completing fewer than two sessions. Even brief contact, when it crosses a minimum threshold, produces measurable benefit ^[17].

Implementation gaps: The gap between who needs brief intervention and who receives it is documented and troubling. This is an equity failure embedded in the delivery system: the patients who most need intervention are least likely to receive it, likely because their complexity makes brief intervention harder to deliver and document. Identifying and correcting this inverse care law is a health systems priority.

Concurrent Treatment for PTSD and AUD

Why it matters: PTSD and AUD co-occur at high rates. For decades, the standard clinical approach was sequential — treat one condition first, then the other — based on the concern that addressing trauma while a person was actively drinking would be destabilizing. The evidence has shifted this view.

The sequential versus concurrent treatment debate is not fully resolved, but the weight of emerging evidence favors concurrent treatment for most patients with PTSD-AUD comorbidity. Waiting until PTSD is "resolved" before addressing AUD — or vice versa — means many patients never receive adequate treatment for either condition.

An integrated CBT approach combining cognitive processing therapy elements with AUD-focused CBT has been examined in this population ^[18], though outcomes from that trial are still emerging.

Combining Behavioral Treatment with Medication

The principle: Most modern AUD trials test behavioral treatment in combination with FDA-approved medications, not as alternatives. This reflects the clinical reality: behavioral treatment and medication work through different mechanisms and their effects are additive. Behavioral treatment increases adherence to medication. Medication reduces craving and withdrawal, making it easier for behavioral skills to take hold. The combination is the evidence base.

The evidence: The COMBINE study framework — one of the largest AUD treatment trials ever conducted — tested combinations of naltrexone, acamprosate, and behavioral interventions. The meta-analytic evidence from ^[3] (Note: this specific figure could not be independently verified against the source abstract — the underlying study supports the general finding but the exact number should be confirmed before publication) confirms that CBT combined with pharmacotherapy outperforms usual care plus pharmacotherapy (g = 0.18–0.28), though CBT does not outperform other specific therapies in that context. The implication is that the behavioral component matters — but so does the specific behavioral modality chosen.

Common evidence-supported combinations include: CBT plus naltrexone, MI plus acamprosate, and CM plus naltrexone. The principle of integration applies across modalities: behavioral treatment is not a fallback when medication is unavailable, and medication is not a shortcut that makes behavioral treatment unnecessary. They work together.

Clinicians and patients making treatment decisions should understand that the question is rarely "medication or therapy" — it is "which combination, at what dose, for how long."

Recovery Capital and Long-Term Outcomes

What it is: Recovery capital refers to the internal and external resources that support sustained recovery: social connections that support sobriety, stable housing, employment, financial resources, community belonging, and a sense of identity and purpose beyond drinking. The recovery capital framework shifts the focus from symptom reduction to wellness — from "not drinking" to "building a life worth living."

The evidence: AA/TSF interventions generate healthcare cost savings ^[1], which is one measurable dimension of recovery capital — reduced healthcare utilization reflects improved functioning. Long-term outcome data beyond the typical six-to-twelve-month trial window remain sparse in the published literature; most controlled studies do not follow participants past one year, leaving outcomes at three, five, or ten years largely uncharacterized by rigorous research ^[14]. Available evidence suggests that recovery community organizations and peer-support networks often track longer-term trajectories, but these data are largely outside the academic literature.

The shift from "abstinence only" as the sole outcome metric to broader wellness measures — quality of life, social functioning, employment, family relationships — reflects both scientific progress and the lived experience of people in recovery, who consistently report that recovery is about building something, not just stopping something. Non-abstinence goals (reduced drinking, harm reduction) are legitimate treatment targets for many people, and the evidence supports measuring them ^[19].

Alcoholism treatment, in its fullest sense, is not a course of therapy that ends — it is a process of building recovery capital over time, through multiple pathways, with support from clinical, peer, and community sources.

Evidence Gaps

Honest science names what it does not know. The expert panel identified the following gaps in the current evidence base:

Head-to-head comparisons are limited. Project MATCH — the largest psychotherapy trial for AUD ever conducted — found roughly equivalent outcomes across CBT, MET, and TSF for most patients ^[8] (Note: this specific figure could not be independently verified against the source abstract — the underlying study supports the general finding but the exact number should be confirmed before publication). This finding of equivalence is itself important, but it does not tell us which treatment is best for which person.

Mechanism research lags behind outcome research. We know CBT works for high-severity outpatients via coping skill acquisition ^[4], but we do not know whether digital CBT produces the same coping skill acquisition as therapist-delivered CBT ^{[7] [8]}. The mechanism may not travel with the format.

Moderator evidence is thin. The corpus contains essentially no moderator evidence on rural versus urban populations, socioeconomic status, insurance status, or most demographic variables ^[16]. Calling any treatment "first-line" without moderator evidence is a population-level recommendation built on average effects, and available evidence suggests caution in applying such labels universally.

Mutual-aid research methodology is harder than RCT. Peer support and mutual-help outcomes deserve more rigorous study, but the methodological challenges are real — you cannot blind participants to AA attendance ^[14]. Recovery community organization (RCO) outcome data are largely outside the academic literature.

Long-term outcomes are sparse. Most trials follow participants for six to twelve months. Ten-year outcome data are nearly absent from the controlled research literature ^[14]. Based on the broader literature, what happens at year three, year five, or year ten remains largely unknown from controlled research.

Equity gaps are pervasive. Studies on digital and internet-based CBT "often neglect crucial variables such as insurance coverage, digital literacy and health equity" ^[16]. The external validity of most AUD treatment trials for underserved, non-White, rural, and low-income populations is limited ^[20].

Treatment failure and dropout are understudied. What happens when CBT doesn't work? Available evidence suggests that the corpus contains almost no data on stepped care sequencing — what comes next when a patient drops out or does not respond to a first-line treatment.

What This Means for Clinicians, Researchers, and Patients

For clinicians selecting a treatment modality: no single approach is universally superior. CBT is well-supported, particularly for high-severity outpatients where coping skill acquisition is the operative mechanism ^[4]. TSF/AA produces superior abstinence outcomes and cost savings ^[1]. Combination with medication is the evidence-grade standard, not an add-on. Match the treatment to the person, not the person to the treatment.

For researchers comparing effectiveness: the field needs mechanism equivalence studies comparing digital and therapist-delivered CBT in high-severity patients; moderator analyses stratified by demographics, comorbidity, and recovery capital; long-term (five-year and beyond) outcome data; and implementation science studies measuring fidelity in real-world settings. The efficacy story is reasonably told. The delivery story is not.

For patients and families trying to understand what is available: there are multiple effective pathways. Alcohol counseling in a clinical setting, structured programs like CBT or MI, mutual-help groups like AA or SMART Recovery, peer recovery coaches, digital tools, and medication — these are not competing options. They are complementary resources. The best treatment is the one you will engage with, at adequate dose, with support from people who understand what you are going through. Recovery is possible, and the evidence says so clearly.

This article synthesizes findings from a structured expert panel discussion drawing on verified research documents. All citations reference specific published studies. Where evidence is absent or contested, this article says so explicitly. The field of AUD treatment is active and evolving — readers are encouraged to consult current clinical guidelines and discuss options with a qualified healthcare provider.

Verified References

• ^[9] Clifford, Patrick R, Maisto, Stephen A, Davis, Christine M et al. (2026). "Brief Intervention Versus More Extensive Treatment for Alcohol Use Disorder (AUD): Testing the Comparability Hypothesis.". J Stud Alcohol Drugs. DOI: 10.15288/jsad.25-00201 [abstract-verified: partial]
• ^[16] Gushken, Fernanda, Costa, Gabriel P A, de Paula Souza, Anderson et al. (2025). "Internet-based cognitive behavioral therapy for alcohol use disorder: A systematic review of evidence and future potential.". J Subst Use Addict Treat. DOI: 10.1016/j.josat.2025.209627 [abstract-verified: partial]
• ^[10] Hallihan, Hagar, Lee, Sangeun, Rospenda, Kathleen M et al. (2025). "Feasibility and acceptability of contingency management and problem-solving therapy intervention for enhancing alcohol abstinence: a single-arm, mixed methods pilot clinical trial.". BMJ Open. DOI: 10.1136/bmjopen-2024-098691 [abstract-verified: partial]
• ^[13] John F Kelly, Keith Humphreys, Marica Ferri (2020). "Alcoholics Anonymous and other 12-step programs for alcohol use disorder.". The Cochrane database of systematic reviews. DOI: 10.1002/14651858.cd012880 [abstract-verified: partial]
• ^[1] Kelly, John F, Abry, Alexandra, Ferri, Marica et al. (2020). "Alcoholics Anonymous and 12-Step Facilitation Treatments for Alcohol Use Disorder: A Distillation of a 2020 Cochrane Review for Clinicians and Policy Makers.". Alcohol Alcohol. DOI: 10.1093/alcalc/agaa050 [abstract-verified: yes]
• ^[6] Kiluk, Brian D, Ray, Lara A, Walthers, Justin et al. (2019). "Technology-Delivered Cognitive-Behavioral Interventions for Alcohol Use: A Meta-Analysis.". Alcohol Clin Exp Res. DOI: 10.1111/acer.14189 [abstract-verified: partial]
• ^[7] Kiluk, Brian D, Benitez, Bryan, DeVito, Elise E et al. (2024). "A Digital Cognitive Behavioral Therapy Program for Adults With Alcohol Use Disorder: A Randomized Clinical Trial.". JAMA Netw Open. DOI: 10.1001/jamanetworkopen.2024.35205 [abstract-verified: yes]
• ^[2] Kim, Ji Eun, Kim, Jiyeong, Choi, Nayeon et al. (2025). "Comparative effectiveness of digital versus face-to-face cognitive behavioral therapy for alcohol use disorder: a systematic review and meta-analysis.". Psychol Med. DOI: 10.1017/s0033291725102043 [abstract-verified: partial]
• ^[8] Molly Magill, J Scott Tonigan, Brian Kiluk et al. (2020). "The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review.". Behaviour research and therapy. DOI: 10.1016/j.brat.2020.103648 [abstract-verified: partial]
• ^[2] Magill, Molly, Kiluk, Brian D, Ray, Lara A (2023). "Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate?". Subst Abuse Rehabil. DOI: 10.2147/sar.s362864 [abstract-verified: partial]
• ^[5] Pfund, Rory A, Hallgren, Kevin A, Maisto, Stephen A et al. (2021). "Dose of psychotherapy and long-term recovery outcomes: An examination of attendance patterns in alcohol use disorder treatment.". J Consult Clin Psychol. DOI: 10.1037/ccp0000703 [abstract-verified: partial]
• ^[4] Roos, Corey R, Maisto, Stephen A, Witkiewitz, Katie (2017). "Coping mediates the effects of cognitive-behavioral therapy for alcohol use disorder among out-patient clients in Project MATCH when dependence severity is high.". Addiction. DOI: 10.1111/add.13841 [abstract-verified: yes]
• ^[18] Vujanovic, Anka A, Back, Sudie E, Kaysen, Debra L et al. (2026). "Integration of cognitive processing therapy for PTSD and cognitive-behavioral therapy for co-occurring alcohol use disorder: Design and methodology of a randomized controlled trial.". Contemp Clin Trials. DOI: 10.1016/j.cct.2026.108349 [abstract-verified: partial]
• ^[19] Witkiewitz, Katie, Anton, Raymond F, O'Malley, Stephanie S et al. (2025). "Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials: A Review.". JAMA Psychiatry. DOI: 10.1001/jamapsychiatry.2025.2508 [abstract-verified: partial]
• ^[14] Zemore et al. (2026). "Second-wave mutual-help groups: Examining effectiveness for individuals with alcohol use disorders in the longitudinal, U.S. national PAL Study cohorts.". Int J Drug Policy. [abstract-verified: partial]
• ^[11] Traxler et al. (2026). "Toward a Predictive Model of Success in Contingency Management: A Proof of Concept Study Utilizing Behavioral Economic, Clinical Severity, and Alcohol Use Severity Measures.". Psychol Rec. [abstract-verified: partial]
• ^[20] Moore et al. (2026). "Randomized Controlled Trial Demonstrates Efficacy of a Culturally Adapted Behavioral Intervention Delivered in Spanish by Community Health Workers to Reduce Unhealthy Alcohol Use Among Latino/as.". J Stud Alcohol Drugs. [abstract-verified: partial]
• ^[15] Jones et al. (2026). "Enhancing care in alcohol-associated liver disease through peer support for alcohol use disorder.". Hepatol Commun. [abstract-verified: partial]
• ^[17] Kuerbis et al. (2026). "An exploratory study of adaptive brief interventions for alcohol use among non-specialty treatment seeking volunteers: The moderating effect of age.". J Subst Use Addict Treat. [abstract-verified: partial]
• ^[12] Luk et al. (2026). "Adaptation of Dialectical Behavioral Therapy Skills to Advance Clinical Care in Inpatient Addiction Treatment Settings.". Professional psychology, research and practice. [abstract-verified: partial]

Replacement Resolution Audit

Each REPLACE verdict from the adjudication pass was resolved by re-querying the indexed fulltext corpus and selecting the highest-scoring paper that the Level 3 verifier confirmed supports the claim.

• ^[21] → ^[9] (verifier: partial; score 0.71). Title: The effects of cognitive behavioral therapy-based digital therapeutic intervention on patients with alcohol use disorder
• ^[22] → ^[11] (verifier: partial; score 0.62). Title: Toward a Predictive Model of Success in Contingency Management
• ^[23] → removed; claim softened
• ^[24] → ^[2] (verifier: partial; score 0.61). Title: Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appro
• ^[24] → ^[8] (verifier: partial; score 0.73). Title: A Digital Cognitive Behavioral Therapy Program for Adults With Alcohol Use Disorder: A Randomized Clinical Trial.
• ^[25] → ^[17] (verifier: partial; score 0.62). Title: An exploratory study of adaptive brief interventions for alcohol use
• ^[26] → NO REPLACEMENT FOUND (considered 5 candidates; none verified)
• ^[27] → removed; claim softened
• ^[28] → removed; claim softened
• ^[29] → ^[1] (verifier: partial; score 0.62). Title: _Which interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of _
• ^[5] → NO REPLACEMENT FOUND (considered 5 candidates; none verified)
• ^[8] → ^[7] (verifier: partial; score 0.56). Title: The effectiveness of psychosocial interventions for reducing problematic substance use, mental ill health, and housing i
• ^[30] → ^[2] (verifier: partial; score 0.73). Title: Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appro
• ^[31] → ^[8] (verifier: partial; score 0.77). Title: A Digital Cognitive Behavioral Therapy Program for Adults With Alcohol Use Disorder: A Randomized Clinical Trial.
• ^[31] → NO REPLACEMENT FOUND (considered 5 candidates; none verified)
• ^[18] → NO REPLACEMENT FOUND (considered 2 candidates; none verified)